Studies of the Economics of Cancer Prevention, Screening, and Care

The summary for the Studies of the Economics of Cancer Prevention, Screening, and Care grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Agency for Health Care Research and Quality, which is the U.S. government agency offering this grant.

Studies of the Economics of Cancer Prevention, Screening, and Care: It is estimated that the economic burden of cancer in the United States in 2002 was equivalent to $172 billion, including $61 billion in direct medical expenditures. As cancer survival improves and as the U.S. population ages, it is likely that the economic aspects of cancer will loom larger in policy discussions. Over the coming decades the U.S. health care system, including public sector programs such as Medicare and Medicaid, will face the challenge of covering an increasing array of health care procedures and services with fiscal resources that are limited by global budget constraints. Under these circumstances, there will be increased need for understanding how economic resources are used across the cancer continuum, from prevention through end- of-life care, and in the context of different organizational settings, for careful economic evaluation of conventional and innovative cancer control interventions and for a better understanding of how economic factors influence the welfare of cancer patients, and decision process about the use of cancer prevention, screening and treatment interventions. These are the types of issues addressed by this Program Announcement. The Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), and the Agency for Health Care Research and Quality (AHRQ), invite investigator-initiated grant applications for research directed at increasing the knowledge base in the area of the economic aspects of cancer prevention, screening and care. The goal of this program announcement is to generate new economic knowledge that will promote the optimal design of cancer prevention and control trial studies and interventions and will facilitate the formulation of effective health care policy related to cancer prevention and control. NCI has an interest in economic and health services studies with particular emphasis on meeting the goals of the NCI Quality of Cancer Care Initiative (see http://plan.cancer.gov/public/quality.htm). This Program Announcement (PA) also relates to the general health services and outcomes and effectiveness research supported by the AHRQ for a wide range of clinical conditions, including cancer. The overall goal of this Initiative is to enhance the state-of-the-science on the quality of cancer care and inform federal decision making on care delivery, coverage, and regulation. This initiative requests research applications on new methods development, the synthesis and extension of existing methods, and innovative data gathering strategies. Applications that propose to implement actual data collection on a pilot or full-scale basis as well as analytical studies that use existing data and methodology may also be submitted.